Skip to main content
×
×
Home

A high-fat diet containing whole walnuts (Juglans regia) reduces tumour size and growth along with plasma insulin-like growth factor 1 in the transgenic adenocarcinoma of the mouse prostate model

  • Paul A. Davis (a1), Vihas T. Vasu (a2), Kishorchandra Gohil (a2), Hyunsook Kim (a1), Imran H. Khan (a3), Carroll E. Cross (a2) and Wallace Yokoyama (a4)...
Abstract

Prostate cancer (PCa) has been linked to fat intake, but the effects of both different dietary fat levels and types remain inconsistent and incompletely characterised. The effects on PCa in the transgenic adenocarcinoma of the mouse prostate (TRAMP) cancer model of an elevated fat (20 % of energy as fat) diet containing 155 g of whole walnuts were compared to those of an elevated fat (20 % of energy as soyabean oil) diet with matched macronutrients, tocopherols as well as a low-fat (8 % of energy as soyabean oil) diet. Mice, starting at 8 weeks of age, consumed one of the three different diets ad libitum; and prostates, livers and blood were obtained after 9, 18 or 24 weeks of feeding. No differences were observed in whole animal growth rates in either high-fat (HF) diet group, but prostate tumour weight and growth rate were reduced in the walnut diet group. Walnut diet group prostate weight, plasma insulin-like growth factor 1, resistin and LDL were lower at 18 weeks, while no statistically significant prostate weight differences by diet were seen at 9 or 24 weeks. Multiple metabolites in the livers differed by diet at 9 and 18 weeks. The walnut diet's beneficial effects probably represent the effects of whole walnuts' multiple constituents and not via a specific fatty acid or tocopherols. Moreover, as the two HF diets had dissimilar effects on prostate tumour growth rate and size, and yet had the same total fat and tocopherol composition and content, this suggests that these are not strongly linked to PCa growth.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      A high-fat diet containing whole walnuts (Juglans regia) reduces tumour size and growth along with plasma insulin-like growth factor 1 in the transgenic adenocarcinoma of the mouse prostate model
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      A high-fat diet containing whole walnuts (Juglans regia) reduces tumour size and growth along with plasma insulin-like growth factor 1 in the transgenic adenocarcinoma of the mouse prostate model
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      A high-fat diet containing whole walnuts (Juglans regia) reduces tumour size and growth along with plasma insulin-like growth factor 1 in the transgenic adenocarcinoma of the mouse prostate model
      Available formats
      ×
Copyright
Corresponding author
*Corresponding author: Dr P. A. Davis, +1 530 752 8966, email padavis@ucdavis.edu
References
Hide All
1Jemal A, Siegel R, Xu J, et al. (2010) Cancer statistics. CA Cancer J Clin 60, 277300.
2Escobar EL, Gomes-Marcondes MC & Carvalho HF (2009) Dietary fatty acid quality affects AR and PPARgamma levels and prostate growth. Prostate 69, 548558.
3Brown MD, Hart C, Gazi E, et al. (2010) Influence of omega-6 PUFA arachidonic acid and bone marrow adipocytes on metastatic spread from prostate cancer. Br J Cancer 102, 403413.
4Berquin IM, Min Y, Wu R, et al. (2007) Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids. J Clin Invest 117, 18661875.
5Reese AC, Fradet V & Witte JS (2009) Omega-3 fatty acids, genetic variants in COX-2 and prostate cancer. J Nutrigenet Nutrigenomics 2, 149158.
6Kristal AR, Arnold KB, Neuhouser ML, et al. (2010) Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial. Am J Epidemiol 172, 566577.
7Vissapragada S, Ghosh A, Ringer L, et al. (2010) Dietary n-3 polyunsaturated fatty acids fail to reduce prostate tumorigenesis in the PB-ErbB-2x Pten(+/ − ) preclinical mouse model. Cell Cycle 9, 18241829.
8Szymanski KM, Wheeler DC & Mucci LA (2010) Fish consumption and prostate cancer risk: a review and meta-analysis. Am J Clin Nutr 92, 12231233.
9Hori S, Butler E & McLoughlin J (2011) Prostate cancer and diet: food for thought? BJU Int 107, 13481359.
10Spaccarotella KJ, Kris-Etherton PM, Stone WL, et al. (2008) The effect of walnut intake on factors related to prostate and vascular health in older men. Nutr J 7, 13.
11Freedland SJ & Aronson WJ (2009) Dietary intervention strategies to modulate prostate cancer risk and prognosis. Curr Opin Urol 19, 263267.
12Lloyd JC, Antonelli JA, Phillips TE, et al. (2010) Effect of isocaloric low fat diet on prostate cancer xenograft progression in a hormone deprivation model. J Urol 183, 16191624.
13Hardman WE & Ion G (2008) Suppression of implanted MDA-MB 231 human breast cancer growth in nude mice by dietary walnut. Nutr Cancer 60, 666674.
14Hardman WE, Ion G, Akinsete JA, et al. (2011) Dietary walnut suppressed mammary gland tumorigenesis in the C(3)1 TAg mouse. Nutr Cancer 63, 960970.
15Nguewa PA & Calvo A (2010) Use of transgenic mice as models for prostate cancer chemoprevention. Curr Mol Med 10, 705718.
16Petrik MB, McEntee MF, Johnson BT, et al. (2000) Highly unsaturated (n-3) fatty acids, but not alpha-linolenic, conjugated linoleic or gamma-linolenic acids, reduce tumorigenesis in Apc(Min/+) mice. J Nutr 130, 24342443.
17Ju YH, Clausen LM, Allred KF, et al. (2004) β-Sitosterol, β-sitosterol glucoside, and a mixture of β-sitosterol and β-sitosterol glucoside modulate the growth of estrogen-responsive breast cancer cells in vitro and in ovariectomized athymic mice. J Nutr 134, 11451151.
18Maguire LS, O'Sullivan SM, Galvin K, et al. (2004) Fatty acid profile, tocopherol, squalene and phytosterol content of walnuts, almonds, peanuts, hazelnuts and the macadamia nut. Int J Food Sci Nutr 55, 171178.
19Han DH, Lee MJ & Kim JH (2006) Antioxidant and apoptosis-inducing activities of ellagic acid. Anticancer Res 26, 36013606.
20Berquin IM, Edwards IJ & Chen YQ (2008) Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Lett 269, 363377.
21Hsu A, Bray TM, Helferich WG, et al. (2010) Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells. Exp Biol Med (Maywood) 235, 9097.
22Jacobs DR Jr, Gross MD & Tapsell LC (2009) Food synergy: an operational concept for understanding nutrition. Am J Clin Nutr 89, 1543S1548S.
23Reeves PG, Nielsen FH & Fahey GC Jr (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123, 19391951.
24Gupta S, Adhami VM, Subbarayan M, et al. (2004) Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model. Cancer Res 64, 33343343.
25Qi J, Nakayama K, Cardiff RD, et al. (2010) Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors. Cancer Cell 18, 2338.
26Xu R, Yokoyama WH, Irving D, et al. (1998) Effect of dietary catechin and vitamin E on aortic fatty streak accumulation in hypercholesterolemic hamsters. Atherosclerosis 137, 2936.
27Brown MB & Forsythe AB (1974) Robust tests for equality of variances. J Amer Statist Assoc 69, 364367.
28Laird NM & Ware JH (1982) Random-effects models for longitudinal data. Biometrics 38, 963974.
29Kris-Etherton PM, Hu FB, Ros E, et al. (2008) The role of tree nuts and peanuts in the prevention of coronary heart disease: multiple potential mechanisms. J Nutr 138, 1746S1751S.
30Adhami VM, Siddiqui IA, Ahmad N, et al. (2004) Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res 64, 87158722.
31Wang L, Bonorden MJ, Li GX, et al. (2009) Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit. Cancer Prev Res (Phila Pa) 2, 484495.
32Wang L, Zhang J, Zhang Y, et al. (2011) Lobe-specific lineages of carcinogenesis in the transgenic adenocarcinoma of mouse prostate and their responses to chemopreventive selenium. Prostate 71, 14291440.
33Freedland SJ, Mavropoulos J, Wang A, et al. (2008) Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis. Prostate 68, 1119.
34Cheon EC, Strouch MJ, Barron MR, et al. (2011) Alteration of strain background and a high omega-6 fat diet induces earlier onset of pancreatic neoplasia in EL-Kras transgenic mice. Int J Cancer 128, 27832792.
35Quiner TE, Nakken HL, Mason BA, et al. (2011) Soy content of basal diets determines the effects of supplemental selenium in male mice. J Nutr 141, 21592165.
36Zhang J, Wang L, Li G, et al. (2011) Mouse prostate proteomes are differentially altered by supranutritional intake of four selenium compounds. Nutr Cancer 63, 778789.
37Key TJ (2011) Diet, insulin-like growth factor-1 and cancer risk. Proc Nutr Soc (epublication ahead of print version 3 May 2011).
38Prasad AS, Mukhtar H, Beck FW, et al. (2010) Dietary zinc and prostate cancer in the TRAMP mouse model. J Med Food 13, 7076.
39Pollak M (2008) Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8, 915928.
40Bonorden MJ, Rogozina OP, Kluczny CM, et al. (2009) Intermittent calorie restriction delays prostate tumor detection and increases survival time in TRAMP mice. Nutr Cancer 61, 265275.
41Thomas JA 2nd, Antonelli JA, Lloyd JC, et al. (2010) Effect of intermittent fasting on prostate cancer tumor growth in a mouse model. Prostate Cancer Prostatic Dis 13, 350355.
42Chen LH, Fang J, Sun Z, et al. (2009) Enterolactone inhibits insulin-like growth factor-1 receptor signaling in human prostatic carcinoma PC-3 cells. J Nutr 139, 653659.
43Gualberto A & Pollak M (2009) Clinical development of inhibitors of the insulin-like growth factor receptor in oncology. Curr Drug Targets 10, 923936.
44Majeed N, Blouin MJ, Kaplan-Lefko PJ, et al. (2005) A germ line mutation that delays prostate cancer progression and prolongs survival in a murine prostate cancer model. Oncogene 24, 47364740.
45Anzo M, Cobb LJ, Hwang DL, et al. (2008) Targeted deletion of hepatic Igf1 in TRAMP mice leads to dramatic alterations in the circulating insulin-like growth factor axis but does not reduce tumor progression. Cancer Res 68, 33423349.
46Sutherland BW, Knoblaugh SE, Kaplan-Lefko PJ, et al. (2008) Conditional deletion of insulin-like growth factor-I receptor in prostate epithelium. Cancer Res 68, 34953504.
47Raina K, Blouin MJ, Singh RP, et al. (2007) Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model. Cancer Res 67, 1108311091.
48Housa D, Vernerova Z, Heracek J, et al. (2008) Serum resistin levels in benign prostate hyperplasia and non-metastatic prostate cancer: possible role in cancer progression. Neoplasma 55, 442446.
49Chung WH, Kim TH, Chang IH, et al. (2009) Relation of resistin to prostate cancer differentiation and aggressiveness. Korean J Urol 50, 540546.
50Kim HJ, Lee YS, Won EH, et al. (2010) Expression of resistin in the prostate and its stimulatory effect on prostate cancer cell proliferation. BJU Int 108, E77E83.
51Housa D, Vernerova Z, Heracek J, et al. (2008) Adiponectin as a potential marker of prostate cancer progression: studies in organ-confined and locally advanced prostate cancer. Physiol Res 57, 451458.
52Grosman H, Fabre B, Mesch V, et al. (2010) Lipoproteins, sex hormones and inflammatory markers in association with prostate cancer. Aging Male 13, 8792.
53Aronis KN, Vamvini MT, Chamberland JP, et al. (2011) Short-term walnut consumption increases circulating total adiponectin and apolipoprotein A concentrations, but does not affect markers of inflammation or vascular injury in obese humans with the metabolic syndrome: data from a double-blinded, randomized, placebo-controlled study. Metabolism (epublication ahead of print version 9 November 2011).
54Solomon KR, Pelton K, Boucher K, et al. (2009) Ezetimibe is an inhibitor of tumor angiogenesis. Am J Pathol 174, 10171026.
55Llaverias G, Danilo C, Wang Y, et al. (2010) A Western-type diet accelerates tumor progression in an autochthonous mouse model of prostate cancer. Am J Pathol 177, 31803191.
56Krycer JR, Kristiana I & Brown AJ (2009) Cholesterol homeostasis in two commonly used human prostate cancer cell-lines, LNCaP and PC-3. PLoS ONE 4, e8496.
57Krauss RM (2010) Lipoprotein subfractions and cardiovascular disease risk. Curr Opin Lipidol 21, 305311.
58Kok DE, van Roermund JG, Aben KK, et al. (2011) Blood lipid levels and prostate cancer risk; a cohort study. Prostate Cancer Prostatic Dis 14, 340345.
59Ohlsson C, Mohan S, Sjogren K, et al. (2009) The role of liver-derived insulin-like growth factor-I. Endocr Rev 30, 494535.
60Brasky TM, Till C, White E, et al. (2011) Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial. Am J Epidemiol 173, 14291439.
61Risbridger GP, Davis ID, Birrell SN, et al. (2010) Breast and prostate cancer: more similar than different. Nat Rev Cancer 10, 205212.
62Hoffmann I (2003) Transcending reductionism in nutrition research. Am J Clin Nutr 78, 514S516S.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Type Description Title
PDF
Supplementary materials

Davis Supplementary Material
Davis Supplementary Material

 PDF (98 KB)
98 KB

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 9
Total number of PDF views: 136 *
Loading metrics...

Abstract views

Total abstract views: 366 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 20th February 2018. This data will be updated every 24 hours.